Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PvdA (AA 1-443) Antikörper (FITC)

Reaktivität: Pseudomonas aeruginosa Wirt: Kaninchen Polyclonal FITC
Produktnummer ABIN7369262
  • Target
    PvdA
    Bindungsspezifität
    AA 1-443
    Reaktivität
    Pseudomonas aeruginosa
    Wirt
    • 4
    Kaninchen
    Klonalität
    • 4
    Polyklonal
    Konjugat
    • 1
    • 1
    • 1
    • 1
    FITC
    Applikation
    Bitte anfragen
    Kreuzreaktivität
    Pseudomonas aeruginosa
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Pseudomonas aeruginosa L-ornithine N(5)-monooxygenase protein (1-443AA)
    Isotyp
    IgG
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    PvdA
    Hintergrund

    Background: Catalyzes the conversion of L-ornithine to N(5)-hydroxyornithine, the first step in the biosynthesis of all hydroxamate-containing siderophores, such as pyoverdin. Pyoverdin is a hydroxamate siderophore composed of a 6,7-dihydroxyquinoline-containing fluorescent chromophore joined to the N-terminus of a partly cyclic octapeptide (D-Ser-L-Arg-D-Ser-L-N(5)-OH-Orn-L-Lys-L-N(5)-OH-Orn-L-Thr-L-Thr in strain PAO1). Specific for NADPH, which plays a role in stabilization of the C4a-hydroperoxyflavin intermediate.

    Aliases: pvdA antibody, pvd-1 antibody, PA2386 antibody, L-ornithine N(5)-monooxygenase antibody, EC 1.14.13.195 antibody, L-ornithine N(5)-hydroxylase antibody, Ornithine hydroxylase antibody, L-ornithine N(5)-oxygenase antibody, Pyoverdin biosynthesis protein A antibody

    UniProt
    Q51548
Sie sind hier: